Charles River Laboratories Denmark ApS: Financial statements 2023
CVR: 42036099
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Charles River Laboratories Denmark ApS (CVR 42036099) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,008,995 and a net result of DKK 192,725 compared with DKK 736,818 the year before. That is a decrease of 47.5% compared with the year before. Equity in the 2023 report amounted to DKK 3,311,230. The solvency ratio was 85.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,008,995
- Profit/Loss
- DKK 192,725
- Equity
- DKK 3,311,230
- Total Assets
- DKK 3,865,025
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2M | 193K | 3.3M | 2 |
| 2022 | - | 3.8M | 737K | 3.1M | 4 |
| 2021 | - | 5.5M | 842K | 2.4M | 5 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Charles River Laboratories Denmark ApS has published its annual report for 2022. Gross profit came to DKK 3,825,068, and the net result was DKK 736,818.
About Charles River Laboratories Denmark ApS
Charles River Laboratories Denmark ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Brian Bathgate, Kerstin Dolph and Rushna Tejani Heneghan. The company is owned by Charles River Nederland B.V.. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 3,651,594 and a net result of DKK 74,021 compared with DKK 426,277 the year before. Equity in the 2025 report amounted to DKK 3,811,528.